181 related articles for article (PubMed ID: 34838000)
1. Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma.
Xia T; Meng L; Zhao Z; Li Y; Wen H; Sun H; Zhang T; Wei J; Li F; Liu C
Cancer Cell Int; 2021 Nov; 21(1):634. PubMed ID: 34838000
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics Analysis and Validation Identify CDK1 and MAD2L1 as Prognostic Markers of Rhabdomyosarcoma.
Lu S; Sun C; Chen H; Zhang C; Li W; Wu L; Zhu J; Sun F; Huang J; Wang J; Zhen Z; Cai R; Sun X; Zhang Y; Zhang X
Cancer Manag Res; 2020; 12():12123-12136. PubMed ID: 33273853
[TBL] [Abstract][Full Text] [Related]
3. CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis.
Li Q; Zhang L; Jiang J; Zhang Y; Wang X; Zhang Q; Wang Y; Liu C; Li F
BMC Med Genomics; 2019 Dec; 12(1):198. PubMed ID: 31870357
[TBL] [Abstract][Full Text] [Related]
4. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
5. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
6. Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis.
Wang M; Wang L; Wu S; Zhou D; Wang X
Int J Genomics; 2019; 2019():3518378. PubMed ID: 31886163
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
Li C; Liu T; Liu Y; Zhang J; Zuo D
J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response.
Tian X; Xu WH; Xu FJ; Li H; Anwaier A; Wang HK; Wan FN; Zhu Y; Cao DL; Zhu YP; Shi GH; Qu YY; Zhang HL; Ye DW
Ann Med; 2022 Dec; 54(1):211-226. PubMed ID: 35037540
[TBL] [Abstract][Full Text] [Related]
9.
Meng L; He X; Hong Q; Qiao B; Zhang X; Wu B; Zhang X; Wei Y; Li J; Ye Z; Xiao Y
Front Oncol; 2021; 11():618187. PubMed ID: 33692955
[TBL] [Abstract][Full Text] [Related]
10. MAD2L1 Functions As a Novel Diagnostic and Predictive Biomarker in Cholangiocarcinoma.
Gao Y; Liu Y; Sun L; Ouyang X; Zhu C; Qin X
Genet Test Mol Biomarkers; 2021 Nov; 25(11):685-695. PubMed ID: 34788140
[No Abstract] [Full Text] [Related]
11. Pathological significance of MAD2L1 in breast cancer: an immunohistochemical study and meta analysis.
Zhu XF; Yi M; He J; Tang W; Lu MY; Li T; Feng ZB
Int J Clin Exp Pathol; 2017; 10(9):9190-9201. PubMed ID: 31966791
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
[TBL] [Abstract][Full Text] [Related]
13. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
[TBL] [Abstract][Full Text] [Related]
14. CCNB2, NUSAP1 and TK1 are associated with the prognosis and progression of hepatocellular carcinoma, as revealed by co-expression analysis.
Liu L; Chen A; Chen S; Song W; Yao Q; Wang P; Zhou S
Exp Ther Med; 2020 Apr; 19(4):2679-2689. PubMed ID: 32256749
[TBL] [Abstract][Full Text] [Related]
15. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
16. Identification of MAD2L1 and BUB1B as Potential Biomarkers Associated with Progression and Prognosis of Ovarian Cancer.
Tang R; Tong J; Shang S; Li G; Sun F; Guan X; Yang J
Biochem Genet; 2024 Apr; ():. PubMed ID: 38683465
[TBL] [Abstract][Full Text] [Related]
17. MYL2 as a potential predictive biomarker for rhabdomyosarcoma.
Wang J; Gao S; Dong K; Guo P; Shan MJ
Medicine (Baltimore); 2021 Oct; 100(39):e27101. PubMed ID: 34596111
[TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J
Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144
[TBL] [Abstract][Full Text] [Related]
19. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
20. High expression of CCNB2 is an independent predictive poor prognostic biomarker and correlates with immune infiltrates in breast carcinoma.
Lu Z; Wang Z; Li G
Heliyon; 2024 May; 10(10):e31586. PubMed ID: 38831807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
